Tipjuta Thawonrat

• Achieved #1 position in TKI space with 49% growth; elevated Tagrisso to top oncology product with 20% Y/Y growth.

• Led access expansion and access strategy for Tagrisso to turn around business, improve profitability, public access expansion

• Led team to list Imfinzi lung OCPA and pioneer to led early-stage lung cancer treatment expansion and reimbursement via multidisciplinary collaboration, strong OCPA committees’ engagement, thoracic surgeon, radio oncology advocacy endorsement

• Built lung cancer franchise strategy and new launch readiness

• Alliance management: Built long term strategy with Daichi for lung cancer portfolio

• Transform sales team and built competitive mindset to be a high-performing teams and readiness for new launch and talent development.

• Transform lung cancer care through advancing lung cancer screening in Thailand through innovative CXR/AI and partnerships with AI providers, medical associations, PAG to establish national policy, collaborated with AI providers, medical associations, patient advocacy groups (PAG), and public hospitals to implement CXR/AI screening, which lead to sustainability and long-term establishment of LC screening in Thailand’s healthcare system.

• Led breast cancer portfolio for Asia Area as a regional talent project, supporting regional launch readiness, strategy implementation

• Cross functional internally and alliance for strategic alignment and ensure excellence execution

• Monitor sales, P&L, Supply chain management

• Orchestrated “Lung Ambition” project, improving screening and policy endorsement.
• Drove Tagrisso to #1 international growth ranking.
• Advanced omnichannel strategy to boost early diagnosis and EGFR testing awareness.
• Supported innovative financial programs and patient funnel alignment across Asia.

• Led “Wcare” digital marketing initiative, capturing LO2 market leadership.
• Listed ZOLADEX for prostate cancer (NLEM).
• Launched AZ CONNECT through Veeva Engage across sales teams.

• Revitalized breast and prostate cancer franchises, achieving 14% growth on key platforms and 90% total portfolio achievement.

• Developed competitive selling models and strategic initiatives, driving oncology sales growth.

• Managed oncology portfolios; led sales teams to top regional performance.

• Regional sales champion for breast, colon, and prostate cancer products.

• Consistently exceeded sales targets, launched new market entries, and received annual service awards.

• Dispensed and provided pharmaceutical consultation, managed inventory, and trained assistants.